Oncotarget

Research Papers:

A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway

Pinghong Ming, Ting Cai, Jin Li, Yong Ning, Shengao Xie, Tao Tao and Faqing Tang _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:41843-41856. https://doi.org/10.18632/oncotarget.9731

Metrics: PDF 1104 views  |   HTML 1342 views  |   ?  


Abstract

Pinghong Ming1,2,*, Ting Cai3,*, Jin Li4,*, Yong Ning2, Shengao Xie2, Tao Tao4, Faqing Tang1

1Department of Clinical Laboratory and Medical Research Center, Zhuhai Hopital of Jinan University, Zhuhai People’s Hospital, Zhuhai, 519000, China

2Hubei University of Traditional Chinese Medicine, Wuhan, 430065, China

3Shenzhen Second People's Hospital, Shenzhen, 518055, China

4China State Institute of Pharmaceutical Industry, Shanghai, 200437, China

*These authors contributed equally to this work

Correspondence to:

Faqing Tang, email: tangfaqing33@hotmail.com

Keywords: cervical cancer, arylbenzofuran, apoptosis, mitochondria, cell cycle

Received: January 20, 2016     Accepted: May 12, 2016     Published: May 31, 2016

ABSTRACT

7-hydroxy-5,4′-dimethoxy-2-arylbenzofuran (Ary) is purified from Livistona. It has been demonstrated to have anticancer activity to various tumors in including cervical cancer, but its mechanism is still unclear. In the present, we show that Ary induces cervical cancer cells apoptosis through mitochondria degradation and mediates cervical cancer cell arrest. Further, Ary-inducing cell cycle G1/S-phase arrest is associated with increased cyclin A2 and cyclin dependent kinase 2 (Cdk2) proteins. Knockdown of cyclin A2 using small interfering RNA (siRNA), and inhibiting Cdk2 activity with flavopiridol, strikingly reduced G1/S-phase arrest. Moreover, Ary sustainedly induced phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2). And ERK1/2 phosphorylation inhibition using specific inhibitor U0126 effectively suppressed cyclin A2 expression, and reduced G1/S-phase arrest induced by Ary. All the experiments in vitro and in vivo verified that Ary has an anticancer effect on cervical cancer. These data provide novel evidences that Ary induces cervical cancer cells apoptosis through mitochondria degradation and cell G1/S-phase arrest. These findings also suggest that ERK-mediated Cdk2/cyclin A signaling pathway is involved in Ary-induced G1/S-phase arrest.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 9731